NervGen Pharma Corp. (NGEN)

2.08 -1.60 (-43.48%) USD  |  NASDAQ  |  May 22, 16:00
2.10 +0.02 (+0.96%) After-Hours: 20:00
More

NervGen Pharma Average Diluted Shares Outstanding (Annual)

Average Diluted Shares Outstanding (Annual) Chart

View Average Diluted Shares Outstanding (Annual) for NGEN.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Average Diluted Shares Outstanding (Annual) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Average Diluted Shares Outstanding (Annual) Range, Past 5 Years

View Average Diluted Shares Outstanding (Annual) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Average Diluted Shares Outstanding (Annual) Benchmarks

View Average Diluted Shares Outstanding (Annual) Benchmarks
Start Trial
CannaPharmaRx, Inc. Upgrade
Lexaria Bioscience Corp. Upgrade
InMed Pharmaceuticals, Inc. Upgrade
Target Group, Inc. (Canada) Upgrade
Tilray Brands, Inc. Upgrade